BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24599412)

  • 1. Breast-conserving therapy: a viable option for young women with early breast cancer--evidence from a prospective study.
    Xie Z; Wang X; Lin H; Wei W; Liu P; Xiao X; Xie X; Guan X; Yang M; Tang J
    Ann Surg Oncol; 2014 Jul; 21(7):2188-96. PubMed ID: 24599412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
    Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
    Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.
    van der Sangen MJ; Poortmans PM; Scheepers SW; Lemaire BM; van Berlo CL; Tjan-Heijnen VC; Voogd AC
    Eur J Surg Oncol; 2013 Aug; 39(8):892-8. PubMed ID: 23726902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort.
    Cao JQ; Truong PT; Olivotto IA; Olson R; Coulombe G; Keyes M; Weir L; Gelmon K; Bernstein V; Woods R; Speers C; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):509-17. PubMed ID: 25194665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is mastectomy superior to breast-conserving treatment for young women?
    Coulombe G; Tyldesley S; Speers C; Paltiel C; Aquino-Parsons C; Bernstein V; Truong PT; Keyes M; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1282-90. PubMed ID: 17275207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
    Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
    Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?
    Parker CC; Ampil F; Burton G; Li BD; Chu QD
    Surgery; 2010 Aug; 148(2):386-91. PubMed ID: 20580045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy.
    Dinshaw KA; Budrukkar AN; Chinoy RF; Sarin R; Badwe R; Hawaldar R; Shrivastava SK
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1132-41. PubMed ID: 15978744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-stage young breast cancer patients: impact of local treatment on survival.
    Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up.
    Kunkler IH; Kerr GR; Thomas JS; Jack WJ; Bartlett JM; Pedersen HC; Cameron DA; Dixon JM; Chetty U;
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):829-38. PubMed ID: 22197227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.
    van Tienhoven G; Voogd AC; Peterse JL; Nielsen M; Andersen KW; Mignolet F; Sylvester R; Fentiman IS; van der Schueren E; van Zijl K; Blichert-Toft M; Bartelink H; van Dongen JA
    Eur J Cancer; 1999 Jan; 35(1):32-8. PubMed ID: 10211085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Oncological Safety of Fat Grafting After Breast-Conserving Therapy: A Prospective Study.
    Mestak O; Hromadkova V; Fajfrova M; Molitor M; Mestak J
    Ann Surg Oncol; 2016 Mar; 23(3):776-81. PubMed ID: 26467459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?
    Vicini FA; Kestin L; Huang R; Martinez A
    Cancer; 2003 Feb; 97(4):910-9. PubMed ID: 12569590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: a meta-analysis.
    Wang J; Xie X; Wang X; Tang J; Pan Q; Zhang Y; Di M
    Surg Oncol; 2013 Dec; 22(4):247-55. PubMed ID: 24144808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients.
    van Laar C; van der Sangen MJ; Poortmans PM; Nieuwenhuijzen GA; Roukema JA; Roumen RM; Tjan-Heijnen VC; Voogd AC
    Eur J Cancer; 2013 Oct; 49(15):3093-101. PubMed ID: 23800672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer.
    Agarwal S; Pappas L; Neumayer L; Kokeny K; Agarwal J
    JAMA Surg; 2014 Mar; 149(3):267-74. PubMed ID: 24429935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.